Brief: ORIC Pharma Provides Initial Phase 1B Data for ORIC-944
Jan 8 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS INC - CASH AND INVESTMENTS EXPECTED
TO FUND
OPERATING PLAN INTO 2026
* ORIC PHARMACEUTICALS- AS OF SEPT 30, 2023, CASH, CASH
EQUIVALENTS & INVESTMENTS TOTALED $256.2 MILLION
Source text for Eikon: ID:nGNX6j3Qrg
Further company coverage: ORIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows